Risk factors for headache recurrence after sumatriptan: A study in 366 migraine patients

Cephalalgia

Volumn 16, Issue 4, 1996, Pages 264-269

  Visser, W H ^a   Jaspers, N M W H ^a   De Vriend, R H M ^a   Ferrari, M D ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acute treatment of migraine; Headache recurrence; Migraine; Sumatriptan

Indexed keywords

SUMATRIPTAN;

ADULT; AGED; ARTICLE; COMPLICATION; CONTROLLED STUDY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; ORAL DRUG ADMINISTRATION; RECURRENT DISEASE; RISK FACTOR; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; FEMALE; HEADACHE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; RISK FACTORS; SUMATRIPTAN;

EID: 0030006854     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1996.1604264.x     Document Type: Article

References (19)

1. Plosker GL, McTavish D. Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs 1994;47(4):622-51
2. Rapoport AM, Visser WH, Cutler NR, Alderton CJ, Paulsgrove LA, Davis RL, Ferrari MD. Oral sumatriptan in preventing headache recurrence after treatment of migraine attacks with subcutaneous sumatriptan. Neurology 1995;45:1505-9
3. Ferrari MD, James MH, Bates D, Pilgrim A, Ashford E, Anderson BA, Nappi G. Oral sumatriptan: effect of a second dose, and incidence and treatment of headache recurrences. Cephalalgia 1994;14:330-8
4. Dahlöf C. Headache recurrence after subcutaneous sumatriptan. Lancet 1992;339:425-6
5. Dahlöf C. Headache recurrence after subcutaneous sumatriptan and early treatment. Lancet 1992;340:909
6. Visser WH, de Vriend RHM, Jaspers NMWH, Ferrari MD. Sumatriptan in clinical practice; a two year review of 453 migraine patients. Neurology, in press
7. Ferrari MD, Saxena PR. Clinical and experimental effects of sumatriptan in humans. Trends Pharmacol Sci 1993;14:129-33
8. 1 receptors in migraine pathophysiology and treatment. Eur J Neurol 1995;2:5-21
9. Headache Classification Committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8 Suppl 7:1-96
10. Jaspers NMWH, de Vriend RHM, Visser WH, Ferrari MD. Clinical differences between patients with and without headache recurrence after sumatriptan: a population-based study. In: Clifford Rose F, editor. New advances in headache research, vol. 4. Smith-Gordon, 1994:256
11. Sheftell FD, Weeks RE, Rapoport AM, Siegel S, Baskin S, Arrowsmith F. Subcutaneous sumatriptan in a clinical setting: the first 100 consecutive patients with acute migraine in a tertiary care center. Headache 1994;34:67-72
12. Ashford EA, Lloyd DK, Pilgrim AJ, Ferrari MD. Delayed treatment with sumatriptan does not increase the incidence of headache recurrence. Cephalalgia 1993;13: Suppl 13:159
13. Ensink FBM. The efficacy of sumatriptan in the acute treatment of migraine when taken early or late after attack onset. In: Clifford Rose F, editor. New advances in headache research, vol. 4. Smith-Gordon, 1994:315
14. Dahlöf C, Ekbom K, Persson L. Clinical experiences from Sweden on the use of subcutaneously administered sumatriptan in migraine and cluster headache. Arch Neurol 1994;51: 1256-61
15. Blau JN. Resolution of migraine attacks: sleep and the recovery phase. J Neurol Neurosurg Psychiarr 1982;45:223-6
16. Fowler PA, Lacey LF, Thomas M, Keene ON, Tanner RJN, Baber NS. The clinical pharmacology, pharmacokinetics and metabolism of sumatriptan. Eur Neurol 1991;31:291-4
17. Visser WH, Burggraat J, Muller LM, Schoemaker R, Fowler PA, Cohen AF, Ferrari MD. Pharmacokinetic differences between migraine patients with and without headache relief and between patients with and without headache recurrence after sumatriptan. Br J Clin Pharmacol 1995;39:572P
18. Weiller C, May A, Limmroth V, Juptner M, Kaube H, Schayck Rv, Coenen HH, Diener HC. Brain stem activation in spontaneous human migraine attacks. Nat Med 1995;7: 658-60
19. Fuseau E, Fowler PA, Smith J, Lawlor C. A comparison of the pharmacokinetics of sumatriptan in male and female subjects. In: Clifford Rose F, editor. New advances in headache research, vol. 4. Smith-Gordon, 1994;4:320